AFFIMER
Live / Registered — Registered — Section 71 accepted (as of 03 Jul 2023)
What this means for you
Registered since 14 Jun 2016. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §71 ten-year affidavit of use was due 14 Jun 2026; it can still be filed, with a surcharge, until 14 Dec 2026).
Record
- Serial number
- 79154375
- Registration number
- 4975232
- Mark type
- Word mark
- Filed
- 07 Jan 2014
- Published for opposition
- 26 May 2015
- Registered
- 14 Jun 2016
- Next maintenance filing
- §71 ten-year affidavit of use, due by 14 Jun 2026 (grace period to 14 Dec 2026)
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 001 — Chemicals: Reagents for use in scientific research; reagents for use in scientific screening
- Class 005 — Pharmaceuticals: Reagents for use in veterinary and medical diagnostic tests, except tests in the field of immunohematology and transfusion medicine; reagents for use in medical and veterinary research except screening in the field of immunohematology and transfusion medicine; diagnostic reagents for use in assays of biological samples, particularly blood, except in the field of immunohematology and transfusion medicine; diagnostic reagents for use in assays of samples, particularly blood, except in the field of immunohematology and transfusion medicine; diagnostic reagents for use in medical and veterinary screening, except screening in the field of immunohematology and transfusion medicine; diagnostic preparations for use in relation to food intolerance testing; pharmaceutical substances based on affinity reagents equivalent to antibodies and products comprising them, all for use in medical and/or veterinary screening, except screening in the field of immunohematology and transfusion medicine; [ antigens for diagnostic and/or pharmaceutical purposes other than immunohematology and transfusion medicine; diagnostic and/or pharmaceutical preparations containing antigens, except preparations in the field of immunohematology and transfusion medicine; substrates impregnated with or carrying antigens for diagnostic and/or pharmaceutical purposes other than immunohematology and transfusion medicine; ] affinity reagents equivalent to antibodies for diagnostic and/or pharmaceutical purposes other than immunohematology and transfusion medicine; pharmaceutical or diagnostic preparations containing affinity reagents equivalent to antibodies, except in connection with immunohematology or transfusion medicine; substrates impregnated with or carrying affinity reagents equivalent to antibodies for pharmaceutical purposes other than immunohematology or transfusion medicine [ ; wound dressings medical plasters; antiseptic wipes; diagnostic agents for medical use except in connection with immunohematology and transfusion medicine, containing any of the aforesaid products ]
Owner
- Avacta Limited, Wetherby, GB
- Avacta Limited, GB
- Avacta Limited, GB
Board proceedings on this mark
- Opposition No. 91224016 — Crimson U.S. Assets LLC v. Avacta Limited, filed 22 Sept 2015 (Terminated)
- Extension of Time to Oppose No. 79154375 — CRIMSON U.S. ASSETS LLC v. Avacta Limited, filed 24 Jun 2015 (Terminated)
Prosecution history
- 18 Jul 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 01 Jul 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Jul 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 01 Jul 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 01 Jul 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 01 Jul 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 01 Jul 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 14 Jun 2025 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 15 Apr 2024 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 12 Mar 2024 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 12 Mar 2024 — INVALIDATION PROCESSED
- 03 Mar 2024 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 01 Feb 2024 — INTERNATIONAL REGISTRATION RENEWED
- 03 Jul 2023 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 03 Jul 2023 — REGISTERED-SEC.71 ACCEPTED